跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACTIFEMME - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ACTIFEMME
Authorized
STANDARD
ACTIFEMME
Novast Laboratories, Limited
🇨🇦 Health Canada
Approval Date
Feb 5, 2026
Approval ID
f29d40087ee1d5f3
Company
Novast Laboratories, Limited
Type
Standard
Approval Details
Approval Id
f29d40087ee1d5f3
Drug Approval Canada Name
ACTIFEMME
Product Name
ACTIFEMME
Status
Approved
Status Date
2025-12-02
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
68:16.04 , 68:32.00
Atc Original
G03FA01 NORETHISTERONE AND ESTROGEN
Aig Number
0267813001
Company Name
Novast Laboratories, Limited
Company Address
1 Guangxing Road, Free Trade Zone, Netda Nantong China 226009
Company Detail Path
/organization/novast-laboratories-limited
Company Information
Pharmaceutical Company Name
Novast Laboratories, Limited
Country Name
China
Province Name
江苏省
City Name
nantong,jiangsu,country_cn
Address
No.1, Guangxing Road, Integrated Free Trade Zone, Economic Technology Development Zone, Chongchuan District
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Feb 5, 2026
Approval ID
f29d40087ee1d5f3
Type
Standard
Back to Health Canada Approvals